IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3088 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed9176    
    Printed238    
    Emailed11    
    PDF Downloaded472    
    Comments [Add]    
    Cited by others 16    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2006  |  Volume : 72  |  Issue : 5  |  Page : 346--349

Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: A randomized, double-blind, placebo controlled study


1 Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Pharmacology, Isfahan University of Medical Sciences, Isfahan, Iran
3 Skin diseases and Leishmaniasis Research Center, Isfahan, Iran

Correspondence Address:
Iraji Fariba
Department of Dermatology, Al-zahra Hospital, P.O. Box: 892, Isfahan
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.27749

Rights and Permissions

Background: Actinic keratoses (AKs) are premalignant skin lesions caused by excessive sun exposure. Aims: To explore the therapeutic efficacy of 3% diclofenac in 2.5% hyaluronan gel in the topical treatment of AK. Methods: Sixty-four lesions in 20 patients were evaluated. They were randomized to receive either the active treatment, 3% diclofenac in 2.5% hyaluronan gel or placebo, which consisted of the inactive gel vehicle, hyaluronan for a period of three months. The collected data were analyzed by using Student t- tests. Results: There was a reduction in the lesion size in 64.7% of diclofenac-treated lesions and 34.3% of control lesions during the three-month course of treatment. Only 9.3% of the lesions in the diclofenac group were completely cleared during three months of treatment. During the treatment, no significant side-effect was observed in both groups. Conclusion: Considering the malignant potential of actinic keratoses and the importance of clearing them to prevent their transformation to squamous cell carcinoma, the efficacy of diclofenac gel seen in our study seems to be low. This treatment may be useful for patients who do not tolerate other, more effective kinds of treatment for actinic keratoses.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow